Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Vasoactive intestinal peptide reduces the inflammatory profile in mice infected with Trypanosoma cruzi.

Higyno PM, Mendes PF, Miranda MB, Pereira DE, Mota AP, Nogueira Kde O, Caldas IS, Moura SA, Menezes CA.

Exp Parasitol. 2015 Dec;159:72-8. doi: 10.1016/j.exppara.2015.09.004. Epub 2015 Sep 7.

PMID:
26358268
2.

Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease.

de Paula Costa G, Silva RR, Pedrosa MC, Pinho V, de Lima WG, Teixeira MM, Bahia MT, Talvani A.

Parasite Immunol. 2010 Mar;32(3):202-8. doi: 10.1111/j.1365-3024.2009.01179.x.

3.

Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy.

Corrêa MV, da Costa Rocha MO, de Sousa GR, do Carmo Pereira Nunes M, Gollob KJ, Dutra WO, da Silva Menezes CA.

Hum Immunol. 2013 Oct;74(10):1375-81. doi: 10.1016/j.humimm.2013.06.028. Epub 2013 Jun 22.

PMID:
23800435
4.

Coinfection with different Trypanosoma cruzi strains interferes with the host immune response to infection.

Rodrigues CM, Valadares HM, Francisco AF, Arantes JM, Campos CF, Teixeira-Carvalho A, Martins-Filho OA, Araujo MS, Arantes RM, Chiari E, Franco GR, Machado CR, Pena SD, Faria AM, Macedo AM.

PLoS Negl Trop Dis. 2010 Oct 12;4(10):e846. doi: 10.1371/journal.pntd.0000846.

5.

Lack of Galectin-3 Prevents Cardiac Fibrosis and Effective Immune Responses in a Murine Model of Trypanosoma cruzi Infection.

Pineda MA, Cuervo H, Fresno M, Soto M, Bonay P.

J Infect Dis. 2015 Oct 1;212(7):1160-71. doi: 10.1093/infdis/jiv185. Epub 2015 Mar 24.

PMID:
25805753
6.

Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.

Mukherjee S, Machado FS, Huang H, Oz HS, Jelicks LA, Prado CM, Koba W, Fine EJ, Zhao D, Factor SM, Collado JE, Weiss LM, Tanowitz HB, Ashton AW.

PLoS One. 2011 Feb 15;6(2):e16959. doi: 10.1371/journal.pone.0016959.

7.

Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.

de Souza SM, Vieira PM, Roatt BM, Reis LE, da Silva Fonseca K, Nogueira NC, Reis AB, Tafuri WL, Carneiro CM.

Mol Immunol. 2014 Mar;58(1):92-7. doi: 10.1016/j.molimm.2013.11.007. Epub 2013 Dec 7.

PMID:
24317279
8.
9.

Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.

Waghabi MC, de Souza EM, de Oliveira GM, Keramidas M, Feige JJ, Araújo-Jorge TC, Bailly S.

Antimicrob Agents Chemother. 2009 Nov;53(11):4694-701. doi: 10.1128/AAC.00580-09. Epub 2009 Sep 8.

10.

[TH1 response in the experimental infection with Trypanosoma cruzi].

Cardoni RL, Antúnez MI, Abrami AA.

Medicina (B Aires). 1999;59 Suppl 2:84-90. Spanish.

PMID:
10668248
11.

Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice.

Lo Presti MS, Rivarola HW, Bustamante JM, Fernández AR, Enders JE, Fretes R, Gea S, Paglini-Oliva PA.

Int J Antimicrob Agents. 2004 Jun;23(6):634-6.

PMID:
15194137
12.

Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.

Medeiros GA, Silvério JC, Marino AP, Roffê E, Vieira V, Kroll-Palhares K, Carvalho CE, Silva AA, Teixeira MM, Lannes-Vieira J.

Microbes Infect. 2009 Feb;11(2):264-73. doi: 10.1016/j.micinf.2008.11.012. Epub 2008 Dec 7.

PMID:
19100857
13.

15d-PGJ(2) modulates acute immune responses to Trypanosoma cruzi infection.

Rodrigues WF, Miguel CB, Chica JE, Napimoga MH.

Mem Inst Oswaldo Cruz. 2010 Mar;105(2):137-43.

14.

Blockade of endothelin ET(A)/ET(B) receptors favors a role for endothelin during acute Trypanosoma cruzi infection in rats.

Rachid MA, Camargos ER, Barcellos L, Marques CA, Chiari E, Huang H, Tanowitz HB, Teixeira MM, Machado CR.

Microbes Infect. 2006 Jul;8(8):2113-9. Epub 2006 Jun 6.

PMID:
16844401
15.

Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load.

Vazquez BP, Vazquez TP, Miguel CB, Rodrigues WF, Mendes MT, de Oliveira CJ, Chica JE.

Parasit Vectors. 2015 Apr 3;8:206. doi: 10.1186/s13071-015-0811-8.

16.

Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease.

Esper L, Roman-Campos D, Lara A, Brant F, Castro LL, Barroso A, Araujo RR, Vieira LQ, Mukherjee S, Gomes ER, Rocha NN, Ramos IP, Lisanti MP, Campos CF, Arantes RM, Guatimosim S, Weiss LM, Cruz JS, Tanowitz HB, Teixeira MM, Machado FS.

Am J Pathol. 2012 Jul;181(1):130-40. doi: 10.1016/j.ajpath.2012.03.042. Epub 2012 May 29.

17.

Role of vasoactive intestinal peptide in inflammation and autoimmunity.

Gonzalez-Rey E, Delgado M.

Curr Opin Investig Drugs. 2005 Nov;6(11):1116-23. Review.

PMID:
16312132
18.

Osteopontin-dependent regulation of Th1 and Th17 cytokine responses in Trypanosoma cruzi-infected C57BL/6 mice.

Santamaría MH, Corral RS.

Cytokine. 2013 Feb;61(2):491-8. doi: 10.1016/j.cyto.2012.10.027. Epub 2012 Nov 28.

PMID:
23199812
19.

Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.

Keino H, Kezuka T, Takeuchi M, Yamakawa N, Hattori T, Usui M.

Arch Ophthalmol. 2004 Aug;122(8):1179-84.

PMID:
15302659
20.

Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.

Solana ME, Alba Soto CD, Fernández MC, Poncini CV, Postan M, González Cappa SM.

Parasitology. 2009 May;136(6):627-39. doi: 10.1017/S0031182009005770. Epub 2009 Apr 14.

PMID:
19366478

Supplemental Content

Support Center